High plasma HDL-C attenuates stress hyperglycemia during acute phase of myocardial infarction

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 231-236

  Carvalho, Luiz Sergio F ^b   Cintra, Riobaldo M R ^b   Moura, Filipe A ^b   Martins, Naiara V G ^b   Quinaglia e Silva, Jose C ^c   Coelho, Otavio R ^a   Sposito, Andrei C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

Author keywords

HDL; Insulin secretion; Insulin sensitivity; Myocardial infarction; Stress hyperglycemia

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGED; ARTICLE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRESS HYPERGLYCEMIA; WAIST CIRCUMFERENCE;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BRAZIL; C-PEPTIDE; CHOLESTEROL, HDL; FEMALE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STRESS, PHYSIOLOGICAL; TIME FACTORS; UP-REGULATION;

EID: 84155170961     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.09.044     Document Type: Article

References (19)

1. Goyal A., Mehta S.R., Gerstein H.C., et al. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J 2009, 157:763-770.
2. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57-65.
3. Falciglia M. Causes and consequences of hyperglycemia in critical illness. Curr Opin Clin Nutr Metab Care 2007, 10:498-503.
4. Heath D.F. Glucose, insulin and other plasma metabolites shortly after injury. J Accid Emerg Med 1994, 11:67-77.
5. van Kooten F., Hoogerbrugge N., Naarding P., Koudstaal P.J. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993, 24:1129-1132.
6. Drew B.G., Duffy S.J., Formosa M.F., et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 2009, 119:2103-2111.
7. Han R., Lai R., Ding Q., et al. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 2007, 50:1960-1968.
8. Abderrahmani A., Niederhauser G., Favre D., et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 2007, 50:1304-1314.
9. Brunham L.R., Kruit J.K., Pape T.D., et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007, 13:340-347.
10. Fryirs M.A., Barter P.J., Appavoo M., et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 2010, 30:1642-1648.
11. Sposito A.C., Carvalho L.S., Cintra R.M., et al. Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis 2009, 207:191-194.
12. Caumo A., Perseghin G., Brunani A., Luzi L. New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method. Diabetes Care 2006, 29:2733-2734.
13. Sierra-Johnson J., Romero-Corral A., Somers V.K., et al. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 2007, 28:2637-2643.
14. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993, 42:1663-1672.
15. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
16. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
17. Vetter N.J., Strange R.C., Adams W., Oliver M.F. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974, 1:284-288.
18. Van Lenten B.J., Hama S.Y., de Beer F.C., et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995, 96:2758-2767.
19. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1 Report. World Health Organization; 2011.